Association between bevacizumab-related hypertension and response to treatment in patients with metastatic colorectal cancer

BACKGROUND: Bevacizumab has become standard of care as first-line treatment of metastatic colorectal cancer (mCRC), after proving increased response rates and improvement in survival outcomes. Hypertension (HTN) is a common complication of the treatment with bevacizumab and, owing to its close relat...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :ESMO Open
Главные авторы: Dionísio de Sousa, Isabel José, Ferreira, Joana, Rodrigues, Joana, Bonito, Nuno, Jacinto, Paula, Marques, Mariela, Ribeiro, João, Pais, Ana, Gervásio, Helena
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Publishing Group 2016
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5070256/
https://ncbi.nlm.nih.gov/pubmed/27843607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2016-000045
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы